Skip to content
Home/Companies/Biotech/TR1X
TR1X

TR1X

Biotech·US·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns TR1X?

TR1X is currently owned by Neva SGR through Neva First (2020 vintage), since 2022.

Hand-verified · updated 2026-07-23

Neva SGR
Investor
Neva SGR
Neva First · 2020 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive
Websitetr1x.bio

More from Neva First

Other portfolio companies in the same fund.

AAVantgarde Bio
Active
BiotechItaly· 2025
NeoPhore
Active
BiotechUK· 2024
Caracol
Caracol
Active
IndustrialsItaly· 2023
CoreTigo
CoreTigo
Active
IndustrialsIsrael· 2023
Energy Dome
Energy Dome
Active
ClimateTechItaly· 2023
Hazy
Exited 2024
Data & AnalyticsUK· 2023
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track TR1X

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy TR1X?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on TR1X.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue